1. 1879 Impact of adjuvant trastuzumab (adjT) for early-stage (ES) breast cancer (BC) on clinical characteristics, survival and likelihood of durable complete response (DCR) of HER2-positive (HER2+) metastatic breast cancer (MBC): A 15-year single-institution cohort study. (September 2015) Authors: Zacchia, A.; Gullo, G.; Parker, I.; De Giorgi, A.; Fennelly, D.; Zanoni, D.; Walshe, J.; Defrein, A.M.; Quinn, C.; Silva, N.; O' Donovan, N.; Ballot, J.; Mc Dermott, E.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. (September 2015) Authors: Gullo, G.; Kennedy, J.; Breathnach, O.; McCaffrey, J.; Keane, M.; Martin, M.; Gupta, R.; Leonard, G.; Calvert, P.; Donnellan, P.; Walshe, J.; Mc Dermott, E.; Cairney, S.; Bose, R.; Scott, K.; Hernando, A.; Parker, I.; Tryfonopoulos, D.; Moulton, B.; Crown, J. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S321 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A pooled analysis of observational studies evaluating the impact of multi-gene assay testing on adjuvant treatment decisions in "real-world" clinical practice for women with early breast cancer. (March 2017) Authors: Millen, S.; Walshe, J. Journal: Breast Issue: Volume 32(2017)Supplement 1 Page Start: S100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bilateral Renal Cortical Necrosis in Meningococcal Meningitis. (22nd November 2011) Authors: Kennedy, C.; Khilji, S.; Dorman, A.; Walshe, J. Other Names: Chiu Y.-L. Academic Editor.; Enríquez R. Academic Editor.; Papagianni A. Academic Editor.; Saxena A. K. Academic Editor. Journal: Case reports in nephrology Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical factors associated with overall survival (OS) for patients with HER2-positive (HER2+) metastatic breast cancer (MBC) treated with HER2-targeting systemic therapy (HER2Tx). (February 2017) Authors: Gullo, G.; Walsh, N.; Zacchia, A.; Hammond, L.; Fennelly, D.; Walshe, J.; O'Mahony, K.; Maltese, M.; Crown, J. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patterns of treatment and outcomes in real world elderly patients with metastatic oestrogen receptor positive (ER+) breast cancer receiving the CDK4/6 inhibitor Palbociclib and endocrine therapy. (October 2020) Authors: Skrobo, D.; Prior, L.; Walshe, J.; Gullo, G.; Crown, J. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Use of contrast-enhanced Magnetic Resonance Imaging (MRI) to predict pathological response after trastuzumab (T) – based neoadjuvant chemotherapy (NAC) for HER2-positive breast cancer (HER2BrCa). (April 2018) Authors: Flynn, C.; Gullo, G.; Walshe, J.; O'doherty, A.; Fennelly, D.; Mcdermott, E.; Crown, J. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗